2 years agoWHO to control Health content on YouTube, to fight spread of 'misinformation' and 'disinformation'TrialSiteNews
2 years agoLitigation counsel for NCLA, speaks about lawsuit against federal government over online censorshipTrialSiteNews
2 years agoNews | UK COVID-19 Hospitalizations Skyrocket Among Heavily Vaccinated PopulationTrialSiteNews
2 years agoPfizer’s First mRNA Data Released While Concerns of Government Pandemic Response MountsTrialSiteNews
2 years agoIsraeli Study Shows Negligible Protection of Pfizer Vaccine Against Viral TransmissionTrialSiteNews
2 years agoMajority of Australians Regret Getting COVID-19 Vaccinations | Australian News Poll SuggestsTrialSiteNews
2 years agoMajority of COVID-19 Deaths In America Occur Among the Vaccinated & Boosted CDC Data RevealsTrialSiteNews
2 years agoNeurosurgeon Dr. Robert Louis Discusses New Virtual Reality Tool for Low Back Pain | InterviewTrialSiteNews
1 year agoNo Help for the Vaccine Injured: The CICP is an Abject Failure, Americans stuck in LimboTrialSiteNews
2 years ago"Everyone needs to know the truth" Former EcoHealth Alliance VP turned whistleblower speaks outTrialSiteNews
1 year agoUK court rules 19 Year Old Woman cannot seek treatment. Doctors seek to put her on end-of-life careTrialSiteNews
1 year agoAustralian Senator Claim: 30K Excess Deaths Caused by mRNA Vax. Calls For InvestigationTrialSiteNews
1 year agoAustralia’s Pharma Regulator Suppressed Troubling Report about Pfizer COVID-19 VaccineTrialSiteNews
2 years agoInvestor Watch | Biotech Hedge Fund Losses Mount but Enormous Sums of Capital AvailableTrialSiteNews
2 years agoFifth Circuit Court of Appeals Shoots Down Tech Platform Censorship: Supreme Court Showdown LikelyTrialSiteNews
2 years agoPursuing Cures: Patrick Girondi talks legal battle to get blood disorder drug released.TrialSiteNews
2 years agoLegal Watch | Cancer Center Accused of Withholding New Product Pivotal For Treatment of Rare DiseaseTrialSiteNews
2 years agoUnprecedented Censorship and the need for Transparent Clinical Research | InterviewTrialSiteNews